Sarah Foulkes , Katie Munro , Dominic Sparkes , Jameel Khawam , Sophie Russell , Angela Dunne , Jean Timeyin , Nipunadi Hettiarachchi , Michelle Cairns , Declan T. Bradley , Elen De Lacy , Kevin Wilson , Nick Andrews , Andre Charlett , Respiratory Virus and Microbiome Initiative (RVI) team , Katie Bellis , Ya-Lin Huang , Matthew Forbes , Andrea Frick-Kretschmer , Marissa Knoll , Victoria Hall
{"title":"2023/24冬季(2023年9月至2024年3月)英国医护人员SARS-CoV-2、流感、呼吸道合胞病毒(RSV)感染和呼吸道疾病的流行及其影响:SIREN队列研究","authors":"Sarah Foulkes , Katie Munro , Dominic Sparkes , Jameel Khawam , Sophie Russell , Angela Dunne , Jean Timeyin , Nipunadi Hettiarachchi , Michelle Cairns , Declan T. Bradley , Elen De Lacy , Kevin Wilson , Nick Andrews , Andre Charlett , Respiratory Virus and Microbiome Initiative (RVI) team , Katie Bellis , Ya-Lin Huang , Matthew Forbes , Andrea Frick-Kretschmer , Marissa Knoll , Victoria Hall","doi":"10.1016/j.jinf.2025.106620","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>During the winter, healthcare systems experience additional pressures due to increases in respiratory infections and staff absence. We aimed to determine the prevalence of respiratory viruses and impact on sickness absence in the SIREN healthcare worker (HCW) cohort during winter 2023/24.</div></div><div><h3>Methods</h3><div>SIREN is a cohort study with linked testing, vaccination, demographic, symptoms and sick leave data. Participants undergo fortnightly multiplex PCR testing for SARS-CoV-2, influenza and RSV, regardless of symptoms. The proportion of participants who took sick leave, the total number and median of sick leave days taken was calculated, overall and stratified by viral infection and vaccination status. Logistic regression was used to estimate the association between sick leave and vaccination status.</div></div><div><h3>Results</h3><div>A total of 5287 participants were included, 78·3% female, median age 54 years. There were 1828 infections (1161 SARS-CoV-2; 387 RSV; 280 influenza infections) among 1659 participants. Influenza and RSV peaked in December (1·2%; 1·9%), SARS-CoV-2 peaked in September and December 2023 (4·0%; 4·3%).</div><div>Regardless of a known infection, 35.8% (1892/5287) took sick leave, resulting in 10,168 days (median 5 days per person; range 1–98 days).</div></div><div><h3>Discussion</h3><div>Respiratory illness caused a substantial burden on the SIREN healthcare workforce over winter, with all three viruses contributing. Reduced number of staff at work and pressures to work through illness have implications for healthcare resilience.</div></div>","PeriodicalId":50180,"journal":{"name":"Journal of Infection","volume":"91 4","pages":"Article 106620"},"PeriodicalIF":11.9000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Prevalence and impact of SARS-CoV-2, influenza, respiratory syncytial virus (RSV) infection and respiratory illness on UK healthcare workers during winter 2023/24 (September 2023 to March 2024): SIREN cohort study\",\"authors\":\"Sarah Foulkes , Katie Munro , Dominic Sparkes , Jameel Khawam , Sophie Russell , Angela Dunne , Jean Timeyin , Nipunadi Hettiarachchi , Michelle Cairns , Declan T. Bradley , Elen De Lacy , Kevin Wilson , Nick Andrews , Andre Charlett , Respiratory Virus and Microbiome Initiative (RVI) team , Katie Bellis , Ya-Lin Huang , Matthew Forbes , Andrea Frick-Kretschmer , Marissa Knoll , Victoria Hall\",\"doi\":\"10.1016/j.jinf.2025.106620\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>During the winter, healthcare systems experience additional pressures due to increases in respiratory infections and staff absence. We aimed to determine the prevalence of respiratory viruses and impact on sickness absence in the SIREN healthcare worker (HCW) cohort during winter 2023/24.</div></div><div><h3>Methods</h3><div>SIREN is a cohort study with linked testing, vaccination, demographic, symptoms and sick leave data. Participants undergo fortnightly multiplex PCR testing for SARS-CoV-2, influenza and RSV, regardless of symptoms. The proportion of participants who took sick leave, the total number and median of sick leave days taken was calculated, overall and stratified by viral infection and vaccination status. Logistic regression was used to estimate the association between sick leave and vaccination status.</div></div><div><h3>Results</h3><div>A total of 5287 participants were included, 78·3% female, median age 54 years. There were 1828 infections (1161 SARS-CoV-2; 387 RSV; 280 influenza infections) among 1659 participants. Influenza and RSV peaked in December (1·2%; 1·9%), SARS-CoV-2 peaked in September and December 2023 (4·0%; 4·3%).</div><div>Regardless of a known infection, 35.8% (1892/5287) took sick leave, resulting in 10,168 days (median 5 days per person; range 1–98 days).</div></div><div><h3>Discussion</h3><div>Respiratory illness caused a substantial burden on the SIREN healthcare workforce over winter, with all three viruses contributing. Reduced number of staff at work and pressures to work through illness have implications for healthcare resilience.</div></div>\",\"PeriodicalId\":50180,\"journal\":{\"name\":\"Journal of Infection\",\"volume\":\"91 4\",\"pages\":\"Article 106620\"},\"PeriodicalIF\":11.9000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Infection\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0163445325002208\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Infection","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0163445325002208","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
Prevalence and impact of SARS-CoV-2, influenza, respiratory syncytial virus (RSV) infection and respiratory illness on UK healthcare workers during winter 2023/24 (September 2023 to March 2024): SIREN cohort study
Background
During the winter, healthcare systems experience additional pressures due to increases in respiratory infections and staff absence. We aimed to determine the prevalence of respiratory viruses and impact on sickness absence in the SIREN healthcare worker (HCW) cohort during winter 2023/24.
Methods
SIREN is a cohort study with linked testing, vaccination, demographic, symptoms and sick leave data. Participants undergo fortnightly multiplex PCR testing for SARS-CoV-2, influenza and RSV, regardless of symptoms. The proportion of participants who took sick leave, the total number and median of sick leave days taken was calculated, overall and stratified by viral infection and vaccination status. Logistic regression was used to estimate the association between sick leave and vaccination status.
Results
A total of 5287 participants were included, 78·3% female, median age 54 years. There were 1828 infections (1161 SARS-CoV-2; 387 RSV; 280 influenza infections) among 1659 participants. Influenza and RSV peaked in December (1·2%; 1·9%), SARS-CoV-2 peaked in September and December 2023 (4·0%; 4·3%).
Regardless of a known infection, 35.8% (1892/5287) took sick leave, resulting in 10,168 days (median 5 days per person; range 1–98 days).
Discussion
Respiratory illness caused a substantial burden on the SIREN healthcare workforce over winter, with all three viruses contributing. Reduced number of staff at work and pressures to work through illness have implications for healthcare resilience.
期刊介绍:
The Journal of Infection publishes original papers on all aspects of infection - clinical, microbiological and epidemiological. The Journal seeks to bring together knowledge from all specialties involved in infection research and clinical practice, and present the best work in the ever-changing field of infection.
Each issue brings you Editorials that describe current or controversial topics of interest, high quality Reviews to keep you in touch with the latest developments in specific fields of interest, an Epidemiology section reporting studies in the hospital and the general community, and a lively correspondence section.